| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |